GlaxoSmithKline S.A.E (EGX: BIOC)
Egypt
· Delayed Price · Currency is EGP
42.20
-3.60 (-7.86%)
At close: Oct 15, 2024
GlaxoSmithKline S.A.E Revenue
GlaxoSmithKline S.A.E had revenue of 642.45M EGP in the quarter ending June 30, 2024, with 19.90% growth. This brings the company's revenue in the last twelve months to 2.60B, up 23.96% year-over-year. In the year 2023, GlaxoSmithKline S.A.E had annual revenue of 2.24B with 22.87% growth.
Revenue (ttm)
2.60B
Revenue Growth
+23.96%
P/S Ratio
1.36
Revenue / Employee
3.25M
Employees
800
Market Cap
3.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24B | 416.99M | 22.87% |
Dec 31, 2022 | 1.82B | 11.19M | 0.62% |
Dec 31, 2021 | 1.81B | -180.79M | -9.07% |
Dec 31, 2020 | 1.99B | 288.80M | 16.95% |
Dec 31, 2019 | 1.70B | 80.66M | 4.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition